Beautyfarm Med has completed the acquisition of 100% equity of Shanghai Siyanli Industry.

Beautyfarm Med (02373) announced that it has acquired 100% of the issued shares of Shanghai Siyanli Industrial Co., Ltd. through the issuance of consideration shares under special authorization. All prerequisites set forth in the share purchase agreement have been met, and the delivery was completed on January 7, 2026 in accordance with the terms and conditions of the share purchase agreement. Following the delivery and as of the date of this announcement, the target company has become an indirect wholly-owned subsidiary of the company, and its operating performance and financial condition will be consolidated into the group's financial statements. According to the share purchase agreement, the company has issued and issued 15,791,000 consideration shares to SYL Holding at an issuance price of HK$28.71 per share, representing approximately 6.28% of the total number of issued shares after the expansion. MBK Partners' strategic investment in Beautyfarm through this transaction demonstrates its high recognition of the group's business development and future growth potential.